Conduit Pharmaceuticals Debt to Equity

The latest debt-to-equity ratio for CDT is 0.95. That is above the sector sector average of 0.14. Investors often review this figure alongside Conduit Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, CDT currently prints 0.95 for debt-to-equity ratio, while the sector average sits near 0.14. That is roughly 588.4% above the sector mean. Large gaps often invite a closer look at Conduit Pharmaceuticals's growth, margins, and balance sheet.

A debt-to-equity ratio of 0.95 for Conduit Pharmaceuticals is not 'good' or 'bad' on its own. Compare it with the peer average (0.14) and with CDT's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting CDT's debt-to-equity ratio (0.95), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.